Lameness at Walk | Meloxicam | Placebo | |||
---|---|---|---|---|---|
Day | Grade | N | % | N | % |
Day 0 | None (0) | 22 | 71.0 | 21 | 72.4 |
Minimal (1) | 1 | 3.2 | 4 | 13.8 | |
Mild (2) | 8 | 25.8 | 4 | 13.8 | |
Moderate to severe (3–5)1 | 0 | 0.0 | 0 | 0.0 | |
Day 1 | None (0) | 20 | 64.5 | 16 | 55.2 |
Minimal (1) | 2 | 6.5 | 6 | 20.7 | |
Mild (2) | 9 | 29.0 | 7 | 24.1 | |
Moderate to severe (3–5)1 | 0 | 0.0 | 0 | 0.0 | |
Day 3 | None (0) | 22 | 71.0 | 19 | 65.5 |
Minimal (1) | 7 | 22.6 | 6 | 20.7 | |
Mild (2) | 2 | 6.5 | 3 | 10.3 | |
Moderate to severe (3–5)1 | 0 | 0.0 | 1 | 3.4 | |
Day 6 | None (0) | 29 | 93.5 | 23 | 79.3 |
Minimal (1) | 2 | 6.5 | 4 | 13.8 | |
Mild (2) | 0 | 0.0 | 2 | 6.9 | |
Moderate to severe (3–5)1 | 0 | 0.0 | 0 | 0.0 | |
Total | 31 | 100.0 | 29 | 100.0 |